Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Balsalazide Disodium Capsules USP, 750 mg.
Zydus Lifesciences Ltd announced the commencement of Phase of IV Real World Data Registry trial EVIDENCES- XI for Saroglitazar Magnesium in Non-Alcoholic Fatty Liver Disease patients with comorbidities.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg.
Zydus Lifesciences Ltd., today announced that the group s animal health drug manufacturing facility at SEZ, Ahmedabad underwent a USFDA inspection from 30th May to 2nd June, 2023. The inspection closed with nil observations.